Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(3,4-dihydro-8,8-dimethyl-2h,8h-benzo(1,2-b:3,4-b')dipyran-3-yl)-1,3-benzenediol
1. 59870-68-7
2. 4-[(3r)-8,8-dimethyl-3,4-dihydro-2h-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol
3. 4-(3,4-dihydro-8,8-dimethyl-2h,8h-benzo(1,2-b:3,4-b')dipyran-3-yl)-1,3-benzenediol
4. Chebi:5369
5. Hoc5567t41
6. (r)-4-(8,8-dimethyl-2,3,4,8-tetrahydropyrano[2,3-f]chromen-3-yl)benzene-1,3-diol
7. 1,3-benzenediol, 4-(3,4-dihydro-8,8-dimethyl-2h,8h-benzo(1,2-b:3,4-b')dipyran-3-yl)-, (r)-
8. Q-100692
9. (r)-glabridin
10. (r)-4-(8,8-dimethyl-3,4-dihydro-2h,8h-pyrano[2,3-f]chromen-3-yl)benzene-1,3-diol
11. 4-[(3r)-8,8-dimethyl-2h,3h,4h,8h-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol
12. 4-[(3r)-8,8-dimethyl-3,4-dihydro-2h,8h-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol
13. Glabioidin
14. Unii-hoc5567t41
15. 1,3-benzenediol, 4-((3r)-3,4-dihydro-8,8-dimethyl-2h,8h-benzo(1,2-b:3,4-b')dipyran-3-yl)-
16. 1,3-benzenediol, 4-[(3r)-3,4-dihydro-8,8-dimethyl-2h,8h-benzo[1,2-b:3,4-b']dipyran-3-yl]-
17. Mfcd03427694
18. Ls-176045
19. Glabridin [inci]
20. Glabridin [who-dd]
21. Mls000697609
22. Bidd:er0172
23. Glabridin, Analytical Standard
24. Schembl114869
25. Amy381
26. Chembl480477
27. Dtxsid00208589
28. Hms2271g14
29. Hms3885m04
30. Hy-n0393
31. Zinc4098719
32. Bdbm50441626
33. Lmpk12080012
34. S3786
35. Stl566095
36. Akos015903270
37. Glabridin, >=98% (hplc), Powder
38. Ccg-223443
39. 4-[(3r)-3,4-dihydro-8,8-dimethyl-2h,8h-benzo[1,2-b:3,4-b']dipyran-3-yl]-1,3-benzenediol
40. Ncgc00247524-01
41. Ac-31452
42. As-74264
43. Smr000470944
44. Kb-289522
45. Cs-0008929
46. N1579
47. 870g687
48. A913838
49. Q2386110
50. 4-[(3r)-8,8-dimethyl-3,4-dihydro-2h-pyrano[2,3-f]chromen- 3-yl]benzene-1,3-diol
51. 4-[(3r)-8,8-dimethyl-3,4-dihydro-2h-pyrano[6,5-f]chromen-3-yl]benzene-1,3-diol
52. 1,3-benzenediol,4-(3,4-dihydro-8,8-dimethyl-2h,8h-benzo(1,2-b:3,4-b')dipyran-3-yl)-,(r); 4-(3,4-dihydro-8,8-dimethyl-2h,8h-benzo(1,2-b:3,4-b')dipyran-3-yl)-1,3-benzenediol
53. 1,3-benzenediol,4-(3,4-dihydro-8,8-dimethyl-2h,8h-benzo[1,2-b:3,4-b']dipyran-3-yl)-,(r)-
54. 4-((r)-8,8-dimethyl-3,4-dihydro-2h,8h-benzo[1,2-b:4,3-b']dipyran-3-yl)-benzene-1,3-diol
55. 4-[(3r)-8,8-dimethyl-3,4-dihydro-2h,8h-benzo[1,2-b:3,4-b']dipyran-3-yl]benzene-1,3-diol
| Molecular Weight | 324.4 g/mol |
|---|---|
| Molecular Formula | C20H20O4 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 324.13615911 g/mol |
| Monoisotopic Mass | 324.13615911 g/mol |
| Topological Polar Surface Area | 58.9 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 488 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Glabridin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glabridin, including repackagers and relabelers. The FDA regulates Glabridin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glabridin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glabridin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glabridin supplier is an individual or a company that provides Glabridin active pharmaceutical ingredient (API) or Glabridin finished formulations upon request. The Glabridin suppliers may include Glabridin API manufacturers, exporters, distributors and traders.
click here to find a list of Glabridin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Glabridin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glabridin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glabridin GMP manufacturer or Glabridin GMP API supplier for your needs.
A Glabridin CoA (Certificate of Analysis) is a formal document that attests to Glabridin's compliance with Glabridin specifications and serves as a tool for batch-level quality control.
Glabridin CoA mostly includes findings from lab analyses of a specific batch. For each Glabridin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glabridin may be tested according to a variety of international standards, such as European Pharmacopoeia (Glabridin EP), Glabridin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glabridin USP).
LOOKING FOR A SUPPLIER?
